Alzheimer's disease is the most common type of dementia that affects memory, thinking, and behavior. According to the Alzheimer’s Association, Alzheimer’s disease accounts for 60-80% of dementia cases. Although common in many dementia cases, Alheimzer’s disease is not a normal part of aging. Alzheimer’s disease is a very serious health issue that often will require professional help from places such as GenCare Lifestyle memory care in Federal Way, WA.

Alzheimer’s disease is not considered a hereditary disease, but it is more commonly developed in families with a history of it. The greatest known risk factor for this disease is increasing age. This is because the majority of people with this disease are over the age of 65. Alzheimer’s disease will come in stages. It typically starts off with mild symptoms, but will progress into more severe memory loss as the person ages. In late stages of Alzheimer’s disease, a person can expect to be put into professional care such as the memory care in Federal Way, WA mentioned above. A person with Alzheimer’s disease can prolong their life expectancy after diagnosis if they seek professional care. However, this also depends on multiple factors in the person’s life.

The most common symptoms for early-stages of Alzheimer’s disease is the difficulty remembering newly learned information. However, these mild symptoms can quickly worsen. As Alzheimer's disease advances through a person’s brain it leads to increasingly severe symptoms like: disorientation, behavior changes, deepening confusion, unfounded suspicions about family, more serious memory loss, mood changes, and difficulty speaking/swallowing/walking.

Typically when symptoms become severe to ones as mentioned then it is important to seek professional care like GenCare Lifestyle memory care in Federal Way, WA. Professionals are trained to deal with diseases like this one, because caring for loved ones with Alzheimer’s disease can be hard on any normal person. Memory care facilities offer services that can help people thrive in their stage of the disease. While also acknowledging their needs and creating a quality of life for all to succeed.

As of today, there is no cure for Alzheimer’s disease. On the other hand, there are treatments that can temporarily slow down the progression of the disease. These treatments are known as aducanumab (Aduhelm™) and lecanemab (Leqembi™). They demonstrate that removing beta-amyloid from the brain reduces cognitive and functional early-stages of decline in the disease.